Related Experiment Video
Updated: May 2, 2026

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
Published on: October 2, 2016
[Phytotherapy threats with emphasis on St. John's wort medicines]
Jacek Sienkiewicz1, Henryk Czarnik-Matusewicz2, Anna Wiela-Hojeńska2
1Uniwersytet Medyczny we Wrocławiu, Katedra i Zakład Farmakologii Klinicznej. jacek.m.sienkiewicz@gmail.com
Abstract:
Plant medicines used by patients in self-treatment contain powerfully acting active substances which can be a source of adverse events including interactions with synthetic medicines. Usage of St. John's wort causes high risk of various complications. St. John's wort preparations shouldn't be combined with antidepressants without physician's consultation. Long-term intake of medicines which contain Hypericum perforatum extracts can be a reason of undesirable interactions with isoenzymes CYP3A4, CYP1A2, CYP2C9, CYP2C19 and P-glycoprotein (P-gp) for which St John's wort is a substrate. Compounds present in the St. John's wort, especially hyperforin, increase the activity of cytochrome P450 in the liver and intestinal mucosa as well as P-gp, which can accelerate their elimination from the body, decrease their concentrations and reduce the effect. Effective and safe phytotherapy requires a lot of knowledge about the properties and toxicity of preparations used and accurate monitoring of the consequences of their actions.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drug toxicity: Drug–Drug Interaction
Pharmaceutical Poisoning: Treatment Strategies
Effects of Chemicals: Overview
Clinical Significance of Antibiotic Resistance
Threats to Biodiversity

